LGALS9 and sarcoma: For high LGALS9 expression, CESC, BRCA, bladder urothelial carcinoma (BLCA), HNSC, MESO, sarcoma (SARC), and SKCM showed worse prognostic probability, while having better patient outcomes for UVM, LGG, and KIRC (Figure S6F).